Clinical research paper in 2D gel electrophoresis for identifying protein biomarkers Transgenomic.
Clinical research paper in 2D gel electrophoresis for identifying protein biomarkers Transgenomic, Inc. and Power3 Medical Products, Inc. today announced the progress on-range publication of a medical research paper entitled Irregular Serum Concentrations of Proteins in Parkinson’s Disease in the scientific journal Biochemical and Biophysical Research Communications super p force . The analysis demonstrates the usefulness of a proteins biomarker panel to distinguish Parkinson’s disease patients from age-matched normal controls independent of the severity of symptoms, using scientific bloodstream serum samples. The analytic technology forms the foundation for the NuroProPD check for PD getting commercialized by Transgenomic according to a licensing/collaboration contract with Power3 Medical signed in early 2009.
Perrine Martin, Scientific Coordinator of the Hepatitis B Program, Department of Infectious Illnesses, Transgene SA. Session Time: 15:30-17:30.. Clinical data of two Transgene products to be presented at EASL Conference Transgene SA , a biopharmaceutical company that develops targeted immunotherapy products to treat major unmet medical requirements in cancers and infectious diseases, today announced that favourable pre-clinical and clinical data on two Transgene products – TG1050 and TG4040 to take care of chronic hepatitis B and chronic hepatitis C , respectively – will be presented in oral presentations at this year's European Association for the Study of the Liver Conference .